Bivirkninger i leveren I de kliniske forsøg med micafungin var den totale incidens af bivirkninger i leveren 8, 6% (260/ 3028) hos patienter, som blev behandlet med micafungin.
Hepatic adverse reactions The overall incidence of hepatic adverse reactions in the patients treated with micafungin in clinical studies was 8.6% (260/3028).